Related Experiment Video
Updated: Jul 15, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment
P Paré1, Ronald Bridges, Malcolm C Champion
1Université Laval and CHAUQ-Hôpital St-Sacrement, Quebec City, Canada. pierre.pare@cha.quebec.qc.ca
This study provides evidence-based treatment recommendations and a clinical algorithm for managing chronic constipation (CC) and irritable bowel syndrome constipation, guiding healthcare professionals. It addresses various treatment options to optimize patient care.
Area of Science:
- Gastroenterology
- Clinical Practice Guidelines
Background:
- Chronic constipation (CC) is highly prevalent in primary care.
- Existing treatment guidelines for CC are lacking, creating challenges for healthcare professionals.
- This paper focuses on primary CC and constipation associated with irritable bowel syndrome (IBS-C).
Purpose of the Study:
- To develop evidence-based treatment recommendations for CC and IBS-C.
- To create a treatment algorithm to guide clinical decision-making.
- To optimize the management approach for constipation in Canadian healthcare settings.
Main Methods:
- A consensus group of 10 gastroenterologists was assembled.
- Recommendations were developed using the Canadian Association of Gastroenterology process.
- An evidence-based approach and expert opinion were utilized, especially where evidence was insufficient.
Main Results:
- Comprehensive recommendations cover epidemiology, quality of life, definitions, diagnostic criteria, and various treatment modalities.
- A treatment algorithm was developed for CC and IBS-C.
- The guidelines aim to clarify the confusing array of treatment options.
Conclusions:
- The developed recommendations and algorithm provide a framework for optimizing CC and IBS-C management.
- This initiative addresses the need for clear guidance in primary care settings.
- The guidelines integrate evidence-based approaches with expert opinion to support physicians.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...